Peptable

Comparison

Tesamorelin vs Tirzepatide

Function

While Tesamorelin is FDA-approved to reduce excess visceral adipose tissue in HIV-associated lipodystrophy and is studied for broader body-composition, NAFLD, and cognitive effects via GH/IGF-1 axis modulation1893, Tirzepatide is approved for type 2 diabetes and obesity, producing larger HbA1c and body-weight reductions than semaglutide in head-to-head trials24.

Mechanism

While Tesamorelin works as a full-length 44-amino-acid GHRH analog with an N-terminal trans-3-hexenoic acid modification that binds GHRHR, activating cAMP/PKA signaling to increase endogenous GH and IGF-1, with improved stability versus native GHRH182893102, Tirzepatide is a 39-amino-acid synthetic peptide primarily based on GIP sequence with C20 fatty diacid conjugation that acts as a dual agonist at GIP and GLP-1 receptors, enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite24.

Receptor

Tesamorelin

Growth hormone–releasing hormone receptor (GHRHR) 9394103

Tirzepatide

Glucose-dependent insulinotropic polypeptide receptor (GIPR) and GLP-1 receptor (GLP1R) 24

Organism or Origin

Tesamorelin

Synthetic analog of human hypothalamic GHRH1893

Tirzepatide

Synthetic dual GIP/GLP-1 receptor agonist modeled on human incretin hormones2480

Gene

Tesamorelin

GHRH

Tirzepatide

Not assigned in the current dataset.

Summary

Both peptides fall into a similar broad context as Hormone peptide and Metabolic peptide, although the details of how they are used and discussed still diverge. Both are often discussed in Metabolic and endocrine and Cardiovascular health contexts, while Tesamorelin is more of a hormone peptide and Metabolic peptide and Tirzepatide is better described as a metabolic peptide and Hormone peptide. Both appear to work through Receptor agonist, but the functional emphasis still separates, with Tesamorelin leaning toward Anabolic growth and Tirzepatide leaning toward Metabolic regulation and Lipolysis and fat loss. Both are synthetic in origin. Tesamorelin carries amidation features, while Tirzepatide instead reflects lipidation and d-amino acid substitution changes.

Sources

18Tesamorelin: Benefits, Dosing & Where to Buy (2026) - Peptides, https://thepeptidecatalog.com/peptides/tesamorelin
28The Ultimate Guide to Tesamorelin | Las Vegas | Sky Health, https://www.skyhealthnv.com/tesamorelin
93Tesamorelin - FDA-Approved GHRH Analog Guide - PeptideMark, https://www.peptidemark.com/peptides/tesamorelin
94Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth-hormone-releasing_hormone_receptor
102Tesamorelin: Molecular Characterization and Metabolic Research, https://biotechpeptides.com/2026/03/25/tesamorelin-molecular-characterization-growth-hormone-axis-modulation-and-metabolic-research/
103Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone_releasing_hormone_receptor
24Tirzepatide - a dual GIP and GLP-1 (GLP1) receptor agonist, https://gpnotebook.com/pages/diabetes-and-endocrinology/tirzepatide-a-dual-gip-and-glp-1-glp1-receptor-agonist
80GLP-1 Localisation and Proglucagon Gene Expression in ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC6200298/